| scholarly article | Q13442814 |
| P356 | DOI | 10.3233/JAD-140651 |
| P698 | PubMed publication ID | 25114071 |
| P50 | author | Bernard J Hanseeuw | Q56989914 |
| P2093 | author name string | Laurence Dricot | |
| Renaud Lhommel | |||
| Adrian Ivanoiu | |||
| Cécile Grandin | |||
| Lisa Quenon | |||
| Nathalie Gilis | |||
| P433 | issue | 3 | |
| P921 | main subject | biomarker | Q864574 |
| Alzheimer's disease | Q11081 | ||
| P304 | page(s) | 835-847 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Journal of Alzheimer's Disease | Q6294755 |
| P1476 | title | Classification of non-demented patients attending a memory clinic using the new diagnostic criteria for Alzheimer's disease with disease-related biomarkers | |
| P478 | volume | 43 |
| Q54980020 | A Systematic Review and Aggregated Analysis on the Impact of Amyloid PET Brain Imaging on the Diagnosis, Diagnostic Confidence, and Management of Patients being Evaluated for Alzheimer's Disease. |
| Q58121166 | Aberrant functional connectivity network in subjective memory complaint individuals relates to pathological biomarkers |
| Q47587631 | Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry |
| Q51761233 | Diagnosis of Alzheimer's disease with Electroencephalography in a differential framework. |
| Q35921321 | Evoked Potentials and Memory/Cognition Tests Validate Brain Atrophy as Measured by 3T MRI (NeuroQuant) in Cognitively Impaired Patients |
| Q38600277 | Imaging β-amyloid using [(18)F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis |
| Q50558815 | Investigating Associative Learning Effects in Patients with Prodromal Alzheimer's Disease Using the Temporal Context Model. |
| Q39466317 | Longitudinal β-Amyloid Deposition and Hippocampal Volume in Preclinical Alzheimer Disease and Suspected Non-Alzheimer Disease Pathophysiology |
| Q35889053 | Memory, executive, and multidomain subtle cognitive impairment: clinical and biomarker findings |
| Q42630406 | NIA-AA staging of preclinical Alzheimer disease: discordance and concordance of CSF and imaging biomarkers |
| Q34507153 | PART and SNAP. |
| Q47863932 | Prediction of Free and Cued Selective Reminding Test Performance Using Volumetric and Amyloid-Based Biomarkers of Alzheimer's Disease |
| Q92584159 | Subjective Cognitive Decline and Alzheimer's Disease Spectrum Disorder |
| Q26771270 | Suspected non-Alzheimer disease pathophysiology--concept and controversy |
Search more.